SGLT2 inhibitors help manage type 2 diabetes but carry a hidden risk: euglycemic diabetic ketoacidosis (euDKA), where dangerous ketone buildup occurs even with normal blood sugar. Learn the signs, who’s at risk, and how to stay safe.
When you hear canagliflozin, a type of SGLT2 inhibitor used to treat type 2 diabetes by helping the kidneys remove excess sugar through urine. Also known as Invokana, it’s not just another pill—it’s a tool that changes how your body handles glucose, not just by lowering blood sugar but by reducing strain on your heart and kidneys. Unlike insulin or metformin, canagliflozin doesn’t rely on your pancreas or liver. Instead, it works directly in your kidneys, blocking a protein called SGLT2 that normally reabsorbs sugar back into your blood. That means sugar you don’t need gets flushed out—naturally, without forcing your body to produce more insulin.
This makes it especially useful for people with type 2 diabetes, a chronic condition where the body doesn’t use insulin properly, leading to high blood sugar levels who also have diabetic kidney disease, a serious complication where high blood sugar damages the kidneys’ filtering system over time. Studies show canagliflozin doesn’t just slow kidney damage—it can actually reduce the risk of needing dialysis or a transplant. It also lowers the chance of heart failure hospitalizations, which is why doctors now often prescribe it even if blood sugar isn’t the main concern.
But it’s not magic. Canagliflozin works best when paired with lifestyle changes: watching carbs, staying hydrated, and moving regularly. It’s not for everyone—people with severe kidney problems, those prone to dehydration, or with a history of genital infections need to be careful. And because it increases urine output, you might notice more trips to the bathroom, especially at first. Some users report mild yeast infections or low blood pressure, especially if they’re also on diuretics or blood pressure meds.
You’ll find posts here that dig into how canagliflozin fits into broader medication safety plans, what happens when it’s mixed with other drugs like hydrochlorothiazide or statins, and why monitoring your kidney function matters just as much as checking your A1C. There are also comparisons with other SGLT2 inhibitors like dapagliflozin and empagliflozin, so you can see which one might suit your body and budget better. Whether you’re just starting this medication or have been on it for years, the information below is designed to help you understand not just how it works—but how to use it safely, effectively, and with confidence.
SGLT2 inhibitors help manage type 2 diabetes but carry a hidden risk: euglycemic diabetic ketoacidosis (euDKA), where dangerous ketone buildup occurs even with normal blood sugar. Learn the signs, who’s at risk, and how to stay safe.